Abstract:A microscale vaccine that SiO2 nanoparticles-loaded in CaCO3 microparticles was constructed through the co-precipitation method, the antigen was covalently conjugated with SiO2 nanoparticles, then these nanoparticles and CpG were co-encapsulated into CaCO3 microparticles, generating the vaccine with a size of approximately 5.2 μm. SEM, EDX, element mapping, and FTIR confirmed the successful preparation of microscale vaccine, which had good storage stability without the sustained release of antigen, and negligible cytotoxicity to dendritic cells (DCs) and macrophages. Compared to SiO2 nanoparticles, the microscale vaccine can significantly improve the antigen/adjuvant uptake. DCs internalized the entire microscale vaccine into lysosome via macropinocytosis, and an increase in antigen endo/lysosomal escape was observed by CLSM. Specifically, DCs pulsed by the vaccine was fully mature, not only expressing high levels of costimulatory molecules (CD40, CD80, CD86), MHC II and MHC I, but also secreting high levels of pro-inflammatory cytokines (IL-12, TNF-α, IL-1β and IL-6). Besides, the vaccine had good in vivo biocompatibility, can protect the antigen from rapid degradation, and increase the retention time in lymph nodes (LNs). SiO2 nanoparticles-in-CaCO3 microparticles was an excellent carrier of antigen/adjuvant delivery. Hopefully, this work can provide some information on the design of microscale carrier for vaccine delivery system.

Self-assembling small-molecule adjuvants as antigen nano-carriers

The application of self-assembled nanostructures in peptide-based subunit vaccine development

Self-Assembled Proteinaceous Nanoparticles for Co-Delivery of Antigens and Cytosine Phosphoguanine (CpG) Adjuvants: Implications for Nanovaccines

Self-Assembly of Soluble Chitosan Derivatives Nanoparticles for Vaccine: Synthesis, Characterization and Evaluation

Identification of a Self-Assembling Small-Molecule Cancer Vaccine Adjuvant with an Improved Toxicity Profile

Adjuvant Delivery Method and Nanoparticle Charge Influence Peptide Amphiphile Micelle Vaccine Bioactivity

Facile Preparation of Carbohydrate‐Containing Adjuvants Based on Self‐Assembling Glycopeptide Conjugates

A Self-Assembling Nanoparticle: Implications for the Development of Thermostable Vaccine Candidates.

Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines

Self-Assembled Nanostructures Presenting Repetitive Arrays of Subunit Antigens for Enhanced Immune Response

Vaccine Platforms: Biosynthesis of Self‐Assembled Proteinaceous Nanoparticles for Vaccination (Adv. Mater. 42/2020)

Self-assembled d -arginine derivatives based on click chemical reactions for intracellular codelivery of antigens and adjuvants for potential immunotherapy

Precise Assembly of Multiple Antigens on Nanoparticles with Specially Designed Affinity Peptides

Adjuvant synergy: The effects of nasal coadministration of adjuvants

Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines

The synthesis and preliminary immunological evaluation of a dual-adjuvant SARS-CoV-2 RBD vaccine: Covalent integration of TLR7/8 and iNKT cell agonists

A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses

A General Strategy toward Self-assembled Nanovaccine Based on Cationic Lentinan to Induce Potent Humoral and Cellular Immune Responses

Polymeric Nanoparticles as a Self‐Adjuvanting Peptide Vaccine Delivery System: The Role of Shape

Programmed nanoparticle-loaded microparticles for effective antigen/adjuvant delivery

Self-Assembly of Immune Signals to Program Innate Immunity through Rational Adjuvant Design